DUBLIN, Ireland, Feb. 02, 2018 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, announced today that Sarah Noonberg, MD, PhD, has decided to resign from her position as Chief Medical Officer.
Name: Sarah Noonberg
Company: Prothena Corp
Position: Chief Medical Officer
Announcement Date: February 01, 2018, 11:00pm
Resignation Date: February 01, 2018, 11:00pm